Cutaneous Miscellaneous: The Dermatology Residents Podcast

• The Next Generation of Topical Treatments: Clinical Pearls for Residents

  In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, welcomes Naiem Issa, MD, for an in-depth discussion on topical therapies in dermatology, covering both traditional treatments and the latest innovations, focusing on tapinarof and roflumilast. The episode begins with a board review of eczematous and papulosquamous diseases, including CARP, asteatotic eczema, nummular dermatitis, and pityriasis rosea, highlighting key diagnostic clues, treatment approaches, and must-know information for residents. They then explore the role of topical therapies in treating psoriasis and atopic dermatitis, emphasizing patient expectations, positioning treatments effectively, and the balance between topicals and systemic options. They provide insights into newer agents like tapinarof and roflumilast, discussing their mechanisms of action, clinical use, and combination strategies for enhanced efficacy. The episode wraps up with practical pearls for residents, including how to navigate access issues, gain hands-on experience with new therapies, and stay updated on emerging therapies. Tune in for a high-yield discussion packed with clinical takeaways!

  --------  

  44:30
• Networking, Education, and More: Why Residents Should Join Dermatology Societies

  In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, welcomes James Del Rosso, DO, to discuss the value of dermatology residents engaging with professional societies and how it can benefit their careers and patients. They begin with a board review on topical and systemic retinoids, highlighting the common applications of the topicals tretinoin, adapalene, and tazarotene as well as an overview of systemic options like isotretinoin and acitretin. They then discuss how residents can leverage professional societies, such as the American Acne and Rosacea Society and the National Psoriasis Foundation, to access networking opportunities, research grants, educational resources, and more. They explore how involvement in societies can support residents, provide resources for patients, and help dermatologists build connections and advance their careers. Tune in to the full episode to learn how professional societies can support your journey through residency and beyond!

  --------  

  35:10
• The Future is Now: How AI Can Help Dermatology Residents

  In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, welcomes guest Stephanie Fabbro, MD, to explore the evolving role of artificial intelligence (AI) in dermatology, with practical applications for residents and early-career dermatologists. They begin with a board review on cutaneous T-cell lymphoma (CTCL) and its most common form, mycosis fungoides (MF), highlighting key diagnostic features, histological findings, and hypopigmented variants in skin of color. They explore treatment options and clinical pearls for CTCL variants like Sézary syndrome and lymphomatoid papulosis. The discussion then transitions to AI’s potential to enhance the residency experience. Dr Fabbro shares insights on using AI for clinical differentials, board prep, and residency candidate selection. She offers practical tips on leveraging AI for time management, staying current with dermatologic research, and simplifying tasks like clinic notes and contract reviews. Tune in to learn how AI can transform your residency experience and support your journey into dermatologic practice!

  --------  

  38:23
• Staying Ahead of the Curve: Embracing New Dermatology Tools and Therapies

  In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, welcomes Brad Glick, DO, to cover to an essential topic for residents and early-career dermatologists: practical approaches for incorporating the latest therapies and technologies into clinical practice. They begin with a board review on psoriatic arthritis. Dr Glick highlights the importance of early evaluation and preventive therapies, shares practical tips on critical questions to ask in clinic, and emphasizes utilizing screening tools to aid in diagnosis. The conversation then shifts to integrating new therapies and technologies into clinical practice. Dr Glick shares insights on adapting to advancements, from targeted biologics to precision tools like the Mind.Px patch, which uses molecular profiling to help dermatologists select the most effective psoriasis treatments for a given patient. Tune in to the full episode for an in-depth look at the evolving landscape of dermatologic care, from board review essentials to real-world strategies for residents looking to adopt breakthrough therapies and tools.

  --------  

  27:23
• Atopic Dermatitis Biologics: The State of the Art

  In this episode of Cutaneous Miscellaneous, Dr. Nicholas Brownstone welcomes Dr Peter Lio, founding director of the Chicago Integrative Eczema Center, to discuss the 3 FDA-approved biologics for atopic dermatitis, focusing on the latest addition, lebrikizumab. With more options for atopic dermatitis come new challenges for clinicians. Dr Lio offers practical insights on differentiating dupilumab, tralokinumab, and lebrikizumab, all targeting the IL-4/13 pathways but with distinct binding and dosing characteristics. He explains his decision-making process for starting biologics, discusses patient education on safety, and provides valuable strategies for navigating insurance. For residents, Dr Lio shares tips on gaining hands-on experience with biologics, staying updated on upcoming treatments like OX40 inhibitors, and key board review topics, including the differences in binding sites, side effects, and dosing protocols of these agents. Tune in to the full episode for high-yield information and clinical pearls for dermatologists navigating the evolving landscape of atopic dermatitis treatments! Need help keeping track of all the approved medications discussed in this episode? Check out our quick-reference chart that includes essential details on FDA-approved ages, dosing, and mechanisms of action for biologics in atopic dermatitis and psoriasis.

  --------  

  32:59

Más podcasts de Salud y forma física

Podcasts a la moda de Salud y forma física

Acerca de Cutaneous Miscellaneous: The Dermatology Residents Podcast

Cutaneous Miscellaneous: The Dermatology Residents Podcast: Podcasts del grupo